James Waisman Selected Research

human ERBB2 protein

4/2018	A single institution experience with palbociclib toxicity requiring dose modifications.
10/2009	Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James Waisman Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 02/2023 - 03/2008
16	Neoplasms (Cancer) 02/2024 - 03/2008
4	Triple Negative Breast Neoplasms 04/2024 - 01/2021
2	Pathologic Complete Response 04/2024 - 04/2014
2	Hyperglycemia 02/2023 - 01/2023
2	Cognitive Dysfunction 01/2020 - 10/2012
2	Neoplasm Metastasis (Metastasis) 07/2017 - 01/2017
1	Exanthema (Rash) 09/2022
1	Lymphopenia (Lymphocytopenia) 09/2022
1	Diarrhea 01/2021
1	Residual Neoplasm 01/2021
1	Neutropenia 04/2018

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 01/2023 - 10/2012
4	pembrolizumabIBA 04/2024 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2017
3	CytokinesIBA 02/2020 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 10/2017 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2008
2	LigandsIBA 02/2024 - 01/2017
2	GlucocorticoidsIBA 02/2023 - 10/2012
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2021
2	palbociclibIBA 01/2021 - 04/2018
2	130-nm albumin-bound paclitaxelIBA 01/2021 - 07/2017
2	human ERBB2 proteinIBA 04/2018 - 10/2009
2	fibrin fragment D (D-dimer)IBA 10/2017 - 08/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 10/2017 - 08/2017
2	Trastuzumab (Herceptin)FDA Link 04/2014 - 10/2009
2	VaccinesIBA 02/2014 - 10/2009
1	Blood Glucose (Blood Sugar)IBA 02/2023
1	Glucose (Dextrose)FDA LinkGeneric 02/2023
1	SteroidsIBA 02/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2023
1	taxaneIBA 02/2023
1	atezolizumabIBA 01/2023
1	ipatasertibIBA 01/2023
1	AlpelisibIBA 01/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	Fulvestrant (Faslodex)FDA Link 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Immune Checkpoint InhibitorsIBA 09/2022
1	ErbB Receptors (EGF Receptor)IBA 09/2022
1	Aromatase InhibitorsIBA 09/2022
1	neratinibIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	PlatinumIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	ostarineIBA 01/2021
1	IronIBA 12/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	C-Reactive ProteinIBA 10/2017
1	Imiquimod (Aldara)FDA LinkGeneric 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2017
1	Albumin-Bound Paclitaxel FDA Link 07/2017
1	ChemokinesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Neutralizing AntibodiesIBA 01/2017
1	pertuzumabIBA 04/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2012
1	Leuprolide (Lupron)FDA LinkGeneric 10/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2009
1	AntigensIBA 10/2009
1	Peptides (Polypeptides)IBA 10/2009
1	EpitopesIBA 10/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2008

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 02/2023 - 04/2014
8	Therapeutics 01/2021 - 03/2008
5	Adjuvant Chemotherapy 07/2019 - 10/2017
2	Neoadjuvant Therapy 04/2024 - 01/2021
2	Drug Tapering 01/2021 - 04/2018
1	Metastasectomy 08/2022
1	Activities of Daily Living (ADL) 10/2017
1	Modified Radical Mastectomy (Mastectomy, Modified) 04/2014